Effects of eythropoietin administration on mitral regurgitation and left ventricular remodeling in heart failure patients.
The effects of erythropoietin administration on mitral regurgitation in patients with congestive heart failure have not yet been examined. After 2 months, erythropoietin treatment results in a significant reduction in left ventricular volumes and mitral regurgitation severity and improves hemodynamics.
